A novel PMoA–PSAS synergy overcomes the cationic dye barrier, boosting mixed-dye decolorization from 25.3% to 92.5%. This, alongside high efficacy across nine dye classes, demonstrates the self-synthesized coagulant's strong application potential.
Min et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: